Combining our immunology and neuroscience expertise, we are continually developing our service offering and expanding to meet client demand.
Our services
We are developing a range of neurotoxicity services, including developmental neurotoxicity assays (DNT), using our pluripotent stem cell and primary CNS cell-based assay platforms that can support Pharma and non-Pharma clients in their regulatory and safety requirements.
We have a suite of cell-based approaches that include cytotoxicity, viability and proliferation assays, mitochondrial toxicity and calcium influx assays.